NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
9.02
+0.41 (4.76%)
At close: Apr 28, 2026, 4:00 PM EDT
9.10
+0.08 (0.89%)
After-hours: Apr 28, 2026, 7:58 PM EDT
NeoGenomics Employees
NeoGenomics had 2,500 employees as of December 31, 2025. The number of employees increased by 300 or 13.64% compared to the previous year.
Employees
2,500
Change (1Y)
300
Growth (1Y)
13.64%
Revenue / Employee
$298,388
Profits / Employee
-$39,683
Market Cap
1.17B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| GeneDx Holdings | 1,300 |
| Twist Bioscience | 979 |
| GRAIL | 910 |
| Castle Biosciences | 883 |
| CareDx | 765 |
NEO News
- 10 hours ago - NeoGenomics Earnings Call Transcript: Q1 2026 - Transcripts
- 10 hours ago - NeoGenomics Reports First Quarter 2026 Results - Business Wire
- 5 days ago - NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration - Business Wire
- 15 days ago - NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026 - Business Wire
- 21 days ago - NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026 - Business Wire
- 6 weeks ago - NeoGenomics' PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling - Business Wire
- 7 weeks ago - NeoGenomics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - NeoGenomics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts